Access Restriction

Author Verstuyf, Annemieke ♦ Vanderschueren, Dirk ♦ Claessens, Frank ♦ Gielen, Evelien ♦ Sinnesael, Mieke ♦ Verschueren, Sabine ♦ Milisen, Koen ♦ Boonen, Steven
Source Directory of Open Access Journals (DOAJ)
Content type Text
Publisher Hindawi Limited
File Format HTM / HTML
Date Created 2012-01-05
Copyright Year ©2011
Language English
Subject Domain (in LCC) R
Subject Keyword Medicine
Abstract Calcium and vitamin D supplements reverse secondary hyperparathyroidism and are widely prescribed to prevent osteoporotic fractures, with proven antifracture efficacy when targeted to individuals with documented insufficiencies. Men who should particularly be considered for calcium and vitamin D supplements include elderly or institutionalized individuals, patients with documented osteoporosis on antiresorptive or anabolic medication, and individuals receiving glucocorticoids. Benefits are most apparent when a daily dose of 1000–1200 mg calcium is complemented with 800 IU vitamin D. Compliance is the key to optimizing clinical efficacy. While (conventionally dosed) vitamin D has not been associated with safety concerns, recent meta-analytic data have provided evidence to suggest that calcium supplements (without coadministered vitamin D) may potentially be associated with cardiovascular risks.
ISSN 20908059
Age Range 18 to 22 years ♦ above 22 year
Educational Use Research
Education Level UG and PG ♦ Career/Technical Study
Learning Resource Type Article
Publisher Date 2011-01-01
e-ISSN 20420064
Journal Journal of Osteoporosis
Volume Number 2011

Source: Directory of Open Access Journals (DOAJ)